Crescent Biopharma (CBIO) Free Cash Flow (2013 - 2026)
Crescent Biopharma (CBIO) reported Free Cash Flow of -$9.0 million for Q1 2026, up 16.63% year-over-year from -$7.8 million in Q1 2025, and up 65.19% on a QoQ basis from -$26.0 million in Q4 2025.
Crescent Biopharma (CBIO) has 14 years of Free Cash Flow data on file, last reported at -$9.0 million in Q1 2026.
- Quarterly Free Cash Flow rose 16.63% year-over-year to -$9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$69.7 million (down 167.94% YoY) and the FY2025 annual result came in at -$71.5 million, down 129.87% from the prior year.
- Free Cash Flow improved to -$9.0 million in Q1 2026 per CBIO's latest filing, from -$26.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$6.3 million in Q4 2024 and bottomed at -$26.0 million in Q4 2025.
- The 5-year median for Free Cash Flow is -$9.8 million (2024), against an average of -$11.7 million.
- The widest annual swing landed in 2023, when Free Cash Flow soared 57.07%; it then sank 314.63% in 2025.
- Tracing CBIO's Free Cash Flow over 5 years: stood at -$7.9 million in 2022, then grew by 3.74% to -$7.6 million in 2023, then advanced by 17.68% to -$6.3 million in 2024, then sank by 314.63% to -$26.0 million in 2025, then surged by 65.19% to -$9.0 million in 2026.
- Per Business Quant, the three latest CBIO Free Cash Flow figures stand at -$9.0 million (Q1 2026), -$26.0 million (Q4 2025), and -$18.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | -9.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.05 Mn |
| Mar 31, 2026 | -9.05 Mn |
| Dec 31, 2025 | -25.99 Mn |
| Dec 31, 2025 | -25.99 Mn |
| Sep 30, 2025 | -18.08 Mn |
| Sep 30, 2025 | -18.08 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Mar 31, 2025 | -10.85 Mn |
| Mar 31, 2025 | -10.85 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Jun 30, 2024 | -8.90 Mn |
| Jun 30, 2024 | -8.90 Mn |
| Mar 31, 2024 | -10.52 Mn |
| Mar 31, 2024 | -10.52 Mn |
| Dec 31, 2023 | -7.62 Mn |
| Dec 31, 2023 | -7.62 Mn |
| Sep 30, 2023 | -8.69 Mn |
| Sep 30, 2023 | -8.69 Mn |
| Jun 30, 2023 | -6.99 Mn |
| Jun 30, 2023 | -6.99 Mn |
| Mar 31, 2023 | -11.61 Mn |
| Mar 31, 2023 | -11.61 Mn |
| Dec 31, 2022 | -7.91 Mn |
| Dec 31, 2022 | -7.91 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -16.27 Mn |
| Jun 30, 2022 | -16.27 Mn |
| Mar 31, 2022 | -13.74 Mn |
| Mar 31, 2022 | -13.74 Mn |
| Dec 31, 2021 | -12.81 Mn |
| Dec 31, 2021 | -12.81 Mn |
| Sep 30, 2021 | -16.95 Mn |
| Sep 30, 2021 | -16.95 Mn |
| Jun 30, 2021 | -13.62 Mn |
| Jun 30, 2021 | -13.62 Mn |
| Mar 31, 2021 | -14.13 Mn |
| Mar 31, 2021 | -14.13 Mn |
| Dec 31, 2020 | -9.74 Mn |
| Dec 31, 2020 | -9.74 Mn |
| Sep 30, 2020 | -11.50 Mn |
| Sep 30, 2020 | -11.50 Mn |
| Jun 30, 2020 | -14.56 Mn |
| Jun 30, 2020 | -14.56 Mn |
| Mar 31, 2020 | -3.51 Mn |
| Mar 31, 2020 | -3.51 Mn |
| Dec 31, 2019 | -12.81 Mn |
| Dec 31, 2019 | -12.81 Mn |
| Sep 30, 2019 | -13.47 Mn |
| Sep 30, 2019 | -13.47 Mn |
| Jun 30, 2019 | -11.47 Mn |
| Jun 30, 2019 | -11.47 Mn |
| Mar 31, 2019 | -14.39 Mn |
| Mar 31, 2019 | -14.39 Mn |
| Dec 31, 2018 | -10.04 Mn |
| Dec 31, 2018 | -10.04 Mn |
| Sep 30, 2018 | -10.11 Mn |
| Sep 30, 2018 | -10.11 Mn |
| Jun 30, 2018 | -13.08 Mn |
| Jun 30, 2018 | -13.08 Mn |
| Mar 31, 2018 | -10.23 Mn |
| Mar 31, 2018 | -10.23 Mn |
| Dec 31, 2017 | -8.40 Mn |
| Dec 31, 2017 | -8.40 Mn |
| Sep 30, 2017 | -6.26 Mn |
| Sep 30, 2017 | -6.26 Mn |
| Jun 30, 2017 | -6.27 Mn |
| Jun 30, 2017 | -6.27 Mn |
| Mar 31, 2017 | -9.12 Mn |
| Mar 31, 2017 | -9.12 Mn |
| Dec 31, 2016 | -6.63 Mn |
| Dec 31, 2016 | -6.63 Mn |
| Sep 30, 2016 | -7.46 Mn |
| Sep 30, 2016 | -7.46 Mn |
| Jun 30, 2016 | -7.10 Mn |
| Jun 30, 2016 | -7.10 Mn |
| Mar 31, 2016 | -9.25 Mn |
| Mar 31, 2016 | -9.25 Mn |
| Dec 31, 2015 | -6.96 Mn |
| Dec 31, 2015 | -6.96 Mn |
| Sep 30, 2015 | 13.51 Mn |
| Sep 30, 2015 | 13.51 Mn |
| Jun 30, 2015 | -6.35 Mn |
| Jun 30, 2015 | -6.35 Mn |
| Mar 31, 2015 | -8.71 Mn |
| Mar 31, 2015 | -8.71 Mn |
| Dec 31, 2014 | -6.17 Mn |
| Dec 31, 2014 | -6.17 Mn |
| Sep 30, 2014 | -4.86 Mn |
| Sep 30, 2014 | -4.86 Mn |
| Jun 30, 2014 | 9.13 Mn |
| Jun 30, 2014 | 9.13 Mn |
| Mar 31, 2014 | -2.60 Mn |
| Mar 31, 2014 | -2.60 Mn |
| Dec 31, 2013 | -5.58 Mn |
| Dec 31, 2013 | -5.58 Mn |
| Sep 30, 2013 | -3.43 Mn |
| Sep 30, 2013 | -3.43 Mn |
| Jun 30, 2013 | -2.73 Mn |
| Jun 30, 2013 | -2.73 Mn |
| Mar 31, 2013 | -3.88 Mn |
| Mar 31, 2013 | -3.88 Mn |